Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 9551–9600 of 34760
Dr. James Kao, who has served as Chair of the Boards for the past three years, will remain on the Board of Directors of the Company and the Bank.
Effective as of the Retirement Date, Mr. McCormick will also retire from the Company’s Board of Directors (the “ Board ”).
On May 14, 2024, Neil Kline notified the board of directors (the "Board") of the Company of his resignation from the Board, effective immediately.
On May 16, 2024, the Board of Directors (“Board”) of GE Vernova Inc. (“Company”) increased its size to nine members and elected Martina Hund-Mejean as a director of the Company, effective immediately, to fill the newly created vacancy.
On May 16, 2024, CSG Systems International, Inc. (“CSG”) announced that it had appointed Samantha Greenberg as a new member of CSG’s Board of Directors (the “Board”), effective May 13, 2024.
On May 10, 2024, the Board of Directors (the “Board”) of Texas Capital Bancshares, Inc. (the “Company”) elected Mark Midkiff as a member of the Board, effective June 1, 2024.
On May 13, 2024, the Board of Directors (the “Board”) of Tennant Company (the “Company”) elected Mark W. Sheahan as a member of the Board effective May 15, 2024.
On May 16, 2024, the Board of Directors (the “Board”) of ArriVent BioPharma, Inc. (the “Company”) appointed John Hohneker, M.D., to the Board, effective as of May 16, 2024 (the “Effective Date”).
On May 16, 2024, Major General Garry C. Dean joined the Board of Directors (the “ Board ”) of Innovative Solutions and Support, Inc. (the “ Company ”) as an independent director for a term until the Company’s next annual meeting of shareholders or until his successor is duly elected and qualified or until his earlier death, disqualification, resignation or removal.
at the Effective Time, Terence Gallagher and Robert McNerney (the “Resigning Directors”) resigned as members of the Board.
at the Effective Time, Terence Gallagher and Robert McNerney (the “Resigning Directors”) resigned as members of the Board.
the following individuals, each of whom was a member of the board of directors of Lakeland immediately prior to consummation of the Merger, were appointed to the board of directors of Provident: Thomas J. Shara, Brian M. Flynn, Brian Gragnolati, James E. Hanson II and Robert E. McCracken.
As of the Effective Time, and pursuant to the terms of the Merger Agreement, Lakeland’s directors and executive officers ceased serving as directors and executive officers of Lakeland.
As of the Effective Time, and pursuant to the terms of the Merger Agreement, Lakeland’s directors and executive officers ceased serving as directors and executive officers of Lakeland.
the following individuals, each of whom was a member of the board of directors of Lakeland immediately prior to consummation of the Merger, were appointed to the board of directors of Provident: Thomas J. Shara, Brian M. Flynn, Brian Gragnolati, James E. Hanson II and Robert E. McCracken.
the following individuals, each of whom was a member of the board of directors of Lakeland immediately prior to consummation of the Merger, were appointed to the board of directors of Provident: Thomas J. Shara, Brian M. Flynn, Brian Gragnolati, James E. Hanson II and Robert E. McCracken.
As of the Effective Time, and pursuant to the terms of the Merger Agreement, Lakeland’s directors and executive officers ceased serving as directors and executive officers of Lakeland.
the following individuals, each of whom was a member of the board of directors of Lakeland immediately prior to consummation of the Merger, were appointed to the board of directors of Provident: Thomas J. Shara, Brian M. Flynn, Brian Gragnolati, James E. Hanson II and Robert E. McCracken.
As of the Effective Time, and pursuant to the terms of the Merger Agreement, Lakeland’s directors and executive officers ceased serving as directors and executive officers of Lakeland.
the following individuals, each of whom was a member of the board of directors of Lakeland immediately prior to consummation of the Merger, were appointed to the board of directors of Provident: Thomas J. Shara, Brian M. Flynn, Brian Gragnolati, James E. Hanson II and Robert E. McCracken.
As of the Effective Time, and pursuant to the terms of the Merger Agreement, Lakeland’s directors and executive officers ceased serving as directors and executive officers of Lakeland.
In accordance with the terms of the Merger Agreement, at the Effective Time, the directors of Merger Sub, Alexander Israel and Travis Kell, became directors of the Company (collectively, the “ New Directors ”).
In accordance with the terms of the Merger Agreement, at the Effective Time, the directors of Merger Sub, Alexander Israel and Travis Kell, became directors of the Company (collectively, the “ New Directors ”).
On May 14, 2024, John Park notified the Company of his intention to resign from the Board of the Company effective on and immediately prior to Mr. Murphy's appointment.
On May 15, 2024, the Board of the Company appointed Steve Murphy as a member of the Board, effective immediately.
On May 14, 2024, the Board of Directors (the “Board”) of International Paper Company (the “Company”) elected Andrew K. Silvernail to the Board effective immediately.
As previously reported in its Current Report on Form 8-K filed on November 6, 2023 (the “Previous Report”), Brian Regli gave written notice of his resignation (the “Resignation Letter”) from the board of directors (the “Board”) of the Company, and from the Audit Committee and Compensation Committee of the Board, effective May 16, 2024.
On May 13, 2024, the Board elected David Reynolds as a director of the Company, effective as of May 16, 2024.
Following the Annual Meeting (as defined below), the board of directors (the “ Board ”) of Spectral AI, Inc., a Delaware corporation (the “ Company ”) unanimously approved the expansion of the Board from six to seven members and appointed Erich Spangenberg to serve as a director on the Company’s Board.
On and effective May 10, 2024, James M. Strock resigned from the Board of Directors (the “Board”) of CVR Energy, Inc. (the “Company”).
On and effective May 16, 2024, the Board appointed Julia Heidenreich Voliva as a member of the Board and as a member and chairperson of the Board’s Nominating and Corporate Governance Committee, and as a member of the Audit Committee and Special Committee – Strategic.
On May 16, 2024, each of Emmanuel Meyer, Huiyan Geng and Joseph C Thomassen, resigned as members of the Board of Directors, effective upon the closing of the Transfer.
On May 16, 2024, each of Emmanuel Meyer, Huiyan Geng and Joseph C Thomassen, resigned as members of the Board of Directors, effective upon the closing of the Transfer.
On May 16, 2024, each of Emmanuel Meyer, Huiyan Geng and Joseph C Thomassen, resigned as members of the Board of Directors, effective upon the closing of the Transfer.
On May16, 2024, effective immediately upon the closing of the Transfer, each of the New Directors was appointed to the Board by the Purchaser
On May16, 2024, effective immediately upon the closing of the Transfer, each of the New Directors was appointed to the Board by the Purchaser
On May16, 2024, effective immediately upon the closing of the Transfer, each of the New Directors was appointed to the Board by the Purchaser
On May 10, 2024, Mr. David LaPre notified the Board of Directors (the “Board”) of Calidi Biotherapeutics, Inc. (the “Company”) of his resignation as a director of the Company, including his position on each Board committee on which he served, effective immediately.
George E. Hansen III retired from the Board of Directors (the "Board") of CrossFirst Bankshares, Inc. (the “Company”), effective immediately prior to the Company’s 2024 Annual Meeting of Shareholders held on May 14, 2024
On May 12, 2024, Ayub Khattak provided notice of his resignation from the Board of Directors (the “Board”) of Cue Health Inc. ("the Company") and all committees thereof, to be effective as of May 14, 2024.
On May 15, 2024, Rishi Reddy provided notice of his resignation from the Board and all committees thereof, effective immediately.
unanimously approved that Machelle Sanders be elected to fill the Class II director vacancy on the Board of the Company, effective May 14, 2024
Effective May 15, 2024, Bruce Holley, Managing Director of Alvarez & Marsal’s Financial Services Industry practice, joined the Board and the Audit and Risk Committee of the Board.
Kenneth Miller was elected to Zebra Technologies Corporation’s (the “Company”) Board of Directors as a Class I director
Tamara Mullings resigned from her position as a director of FTC Solar, Inc. (the “Company”) on May 13, 2024, effective immediately.
On May 15, 2024, the Board of Directors (the “ Board ”) of Syndax Pharmaceuticals, Inc. (the “ Company ”), unanimously voted to elect Aleksandra Rizo, M.D., Ph.D. to the Board, effectively immediately
On May 14, 2024, Briggs W. Morrison, M.D. advised the Board that he will resign from his position as a Class III member of our Board effective immediately.
the Board of Directors (the “Board”) of the Company appointed David Meek as a Class I director, effective May 15, 2024.
Thomas Ebeling notified the Board of his intention to serve out his current term and resign as a director effective as of June 26, 2024.
Eric Kufel, notified the Company of his resignation as a director of the Company, effective as of May 15, 2024.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.